{
    "title": "109_hr3423",
    "content": "The Act titled \"Medical Device User Fee Stabilization Act of 2005\" makes amendments to the Federal Food, Drug, and Cosmetic Act. The \"Medical Device User Fee Stabilization Act of 2005\" amends the Federal Food, Drug, and Cosmetic Act by adjusting device user fees and annual fee setting procedures. The \"Medical Device User Fee Stabilization Act of 2005\" amends the Federal Food, Drug, and Cosmetic Act by adjusting device user fees and annual fee setting procedures. In paragraph (1), the fees for fiscal years 2006 and 2007 are revised, with premarket application fees increased to $281,600. The Secretary may use unobligated carryover balances from previous fiscal years to ensure sufficient funding. The \"Medical Device User Fee Stabilization Act of 2005\" adjusts device user fees for fiscal years 2006 and 2007, with premarket application fees set at $281,600. The Secretary can use unobligated carryover balances from previous years to ensure adequate funding. Notification to Congress is required before utilizing these funds. In fiscal year 2008, the Secretary must notify Congress before using funds. The definition of \"small business\" is clarified as an entity with $30,000,000 or less in gross receipts. The definition of \"small business\" is updated to mean an entity with $30,000,000 or less in gross receipts in its most recent Federal income tax return. This threshold is increased to $100,000,000 in various subsections. The threshold for a \"small business\" is updated to $100,000,000 in various subsections, including the removal of the $30,000,000 limit in certain clauses. For fiscal year 2005, if the appropriated amount is more than 1% less than the threshold of $205,720,000, adjustments will apply. For fiscal year 2005, adjustments will apply if the appropriated amount is more than 1% less than $205,720,000, by striking \"2003 through\" and inserting \"2005 and\", and inserting \"more than 1 percent\" after \"years, is\". In subsection (h)(3), adjustments for fiscal years 2006 and 2007 are necessary. Section 103 of the Medical Device User Fee and Modernization Act of 2002 is amended to include annual reports starting from fiscal year 2005. Section 103 of the Medical Device User Fee and Modernization Act of 2002 is amended to include annual reports for fiscal years 2006 and 2007, with additional information on fees paid by businesses in different revenue categories. The Medical Device User Fee and Modernization Act of 2002 is amended to include annual reports for fiscal years 2006 and 2007, detailing fees paid by businesses in various revenue categories. The Secretary must certify that funds for FDA salaries and expenses related to device functions meet specified requirements. The Federal Food, Drug, and Cosmetic Act is amended to set minimum amounts for fees in fiscal year 2002, adjusted by a factor. Section 502(u) is revised regarding reprocessed single-use devices requiring manufacturer identification. The Federal Food, Drug, and Cosmetic Act is amended to set minimum fees for fiscal year 2002, with adjustments. Section 502(u) is updated for reprocessed single-use devices to include manufacturer identification requirements. Guidance will be issued by the Secretary of Health and Human Services within 180 days to specify circumstances for manufacturer identification. The Secretary of Health and Human Services will issue guidance within 180 days to specify circumstances where manufacturer identification on medical devices is not considered prominent and conspicuous. The Federal Food, Drug, and Cosmetic Act is amended to specify the effective date for devices described under certain sections. The Federal Food, Drug, and Cosmetic Act is amended to specify the effective date for devices described under certain sections, with requirements for devices bearing manufacturer's name, abbreviation, or symbol, and restrictions on reprocessed devices introduced in interstate commerce. The curr_chunk is about the roles of the Speaker of the House of Representatives and the Vice President of the United States as President of the Senate."
}